Genetic association and characterization of FSTL5 in isolated clubfoot by Khanshour, Anas M et al.
 1 










 Alexandra 3 
Rafipay,
3











 Matthew B Dobbs,
6











 Christina A Gurnett,
11







Center for Pediatric Bone Biology and Translational Research, Scottish Rite for 10 
Children, Dallas, TX, 75219, USA 11 
2
McDermott Center for Human Growth and Development, UT Southwestern Medical 12 
Center, Dallas, TX, USA 13 
3
School of Medicine, Medical Sciences & Nutrition, Institute of Medical Sciences, 14 
University of Aberdeen, Foresterhill, Aberdeen, UK 15 
4
Department of Anatomy and Structural Biology, University of Otago, Dunedin 9016, 16 
New Zealand 17 
5
Department of Pediatrics, McGovern Medical School, University of Texas Health, 18 
Houston, TX, USA  19 
6
Paley Orthopedic and Spine Institute, West Palm Beach, FL, USA 20 
7
Department of Orthopaedics, Scottish Rite for Children, Dallas, TX 75219, USA 21 
8




Department of Obstetrics and Gynecology, Cecil H. & Ida Green Center for 24 
Reproductive Biology Sciences, UT Southwestern Medical Center, Dallas, TX, USA 25 
10
Department of Pediatrics, UT Southwestern Medical Center, Dallas, TX, USA 26 
11
Department of Neurology, School of Medicine, Washington University, St. Louis, MO, 27 
USA 28 
*Corresponding author: Jonathan Rios 29 
 (P) 214-648-7658 30 
 (F) 214-559-7872 31 
 (E) Jonathan.Rios@tsrh.org 32 
 33 
Running title: FSTL5 associated with isolated clubfoot 34 
Keywords: genome-wide association study, clubfoot, FSTL5, imputation 35 
Word Count: 7,378 36 
Figures: 4 37 





  41 
 1 
ABSTRACT 42 
 Talipes equinovarus (clubfoot, TEV) is a congenital rotational foot deformity 43 
occurring in 1 per 1,000 births with increased prevalence in males compared to females. 44 
The genetic etiology of isolated clubfoot (iTEV) remains unclear. Using a genome-wide 45 
association study, we identified a locus within FSTL5, encoding follistatin-like 5, 46 
significantly associated with iTEV. FSTL5 is an uncharacterized gene whose potential 47 
role in embryonic and post-natal development were previously unstudied. Utilizing 48 
multiple model systems, we found that Fstl5 was expressed during later stages of 49 
embryonic hindlimb development, and, in mice, expression was restricted to the 50 
condensing cartilage anlage destined to form the limb skeleton. In the post-natal growth 51 
plate, Fstl5 was specifically expressed in pre-hypertrophic chondrocytes. As Fstl5 knock-52 
out rats displayed no gross malformations, we engineered a conditional transgenic mouse 53 
line (Fstl5
LSL
) to over-express Fstl5 in skeletal osteochondroprogenitors. We observed 54 
that hindlimbs were slightly shorter and that bone mineral density was reduced in adult 55 
male, but not female, Prrx1-cre;Fstl5
LSL
 mice compared to control. No overt clubfoot-56 
like deformity was observed in Prrx1-cre;Fstl5
LSL
 mice, suggesting FSTL5 may function 57 
in other cell types to contribute to iTEV pathogenesis. Interrogating published mouse 58 
embryonic single-cell expression data showed Fstl5 was expressed in cell lineage sub-59 
clusters whose transcriptomes were associated with neural system development. 60 
Moreover, our results suggest lineage-specific expression of the Fstl genes correlates 61 
with their divergent roles as modulators of TGF-ß and BMP signaling. Results from this 62 
study associate FSTL5 with iTEV and suggest an potential sexually dimorphic role for 63 
Fstl5 in vivo.   64 
 1 
INTRODUCTION 65 
Talipes equinovarus (clubfoot, TEV) is a congenital rotational foot deformity 66 
occurring in ~1 per 1,000 live births and affecting either or both limbs (1) (Fig. 1A). 67 
Infants are often treated with non-operative methods to gradually manipulate the foot to a 68 
corrected position, though relapse of the deformity may occur and require surgical 69 
intervention (2, 3). Syndromic TEV coincides with other diagnoses, such as cerebral 70 
palsy or spina bifida, and may be caused by single-gene mutations or large chromosomal 71 
abnormalities (1, 4). Most often, however, clubfoot is isolated (iTEV), presenting as a 72 
distal limb malformation without significant co-occurring sequelae. The prenatal 73 
developmental etiology of iTEV remains poorly understood, though it is generally 74 
accepted that bone, muscle, nerve, and tendon may all contribute to its development.  75 
Mendelian inheritance of iTEV has been described in multi-generational families 76 
(5-7). By linkage analysis and resequencing, a novel dominant-negative mutation in 77 
PITX1 segregated with clubfoot in a multi-generational family (8). Subsequent analyses 78 
identified rare copy number variations including the PITX1 or TBX4 genes, among others, 79 
in clubfoot, (9-12), though these account for only a small fraction of clubfoot cases. 80 
While PITX1 haploinsufficiency was implicated in clubfoot, mis-expression of PITX1 81 
from deletion or structural rearrangement of the 5’ regulatory region was shown to cause 82 
Liebenberg syndrome, which is characterized by partial arm-to-leg transformation (13). 83 
Therefore, alterations in these master regulators of limb development, through genetic 84 
mutation, may lead to pleiotropic limb malformations.  85 
Genetically-engineered mouse models have shown haploinsufficiency or mis-86 
expression of Pitx1 results in phenotypes resembling clubfoot and Liebenberg syndrome, 87 
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respectively (9, 13). More recently, a spontaneous mutation in Limk1 was identified in the 88 
“pma” mouse, which develops a fully penetrant recessive clubfoot-like deformity (14). In 89 
homozygous pma/pma mice, increased embryonic hindlimb expression and activation of 90 
Limk1 was associated with inactivation of Cofilin leading to defects in hindlimb muscle 91 
innervation. Results from these and other mouse models (15) suggest multiple 92 
developmental origins of clubfoot.   93 
iTEV is considered a complex genetic disorder likely impacted by a spectrum of 94 
associated genetic loci, and the prevalence varies greatly between ethnic populations and 95 
between genders (1, 5, 16). Here, we report results from a genome-wide associated study 96 
(GWAS) of iTEV, which identified an associated locus within FSTL5. We show Fstl5 is 97 
expressed in the embryonic hindlimb and the post-natal growth plate, and conditional 98 
over-expression of Fstl5 in osteochondroprogenitors resulted in sexually dimorphic 99 
differences in skeletal development. Unlike other Fstl genes, our results suggest Fstl5 100 
likely does not modulate TGF-ß and BMP signaling. Finally, using results from publicly-101 
available mouse embryonic single-cell expression profiling, we provide evidence for a 102 
neurogenic role of Fstl5 in clubfoot.  103 
 104 
RESULTS 105 
FSTL5 is associated with iTEV 106 
To identify novel loci associated with iTEV, we performed a GWAS with 399 Caucasian 107 
iTEV subjects (previously described (17)) and 7,820 ethnicity-matched controls from the 108 
population-based Atherosclerosis Risk in Communities study (dbGAP: phs000280.v3.p1) 109 
(18) (Table S1, Fig. S1A). Following imputation and quality control filtering, 7,794,536 110 
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autosomal variants with overall minor allele frequency >0.02 and imputation quality 111 
(Rsq) >0.3 were tested for association with iTEV using logistic regression, adjusting for 112 
gender and ten principal components. A single locus on chromosome 4 exceeded 113 
genome-wide significance (Fig. 1B, Supplementary Figure 1B,C). The top-associated 114 
variant (rs76973778, Rsq= 0.87, p= 1.92 x10
-8
; OR= 0.35 [0.26-0.60]) was located within 115 
intron 3 of the Follistatin-like 5 (FSTL5) gene (Fig. 1C). Because clubfoot is twice as 116 
frequent in males compared to females (6), we investigated the association of FSTL5 with 117 
iTEV in males and females separately. The FSTL5 association was more strongly evident 118 
in males (P=4.41e
-8
, OR= 0.26 [0.19-0.50]) compared to females (P=0.02, OR= 0.51 119 
[0.33-0.92]), which was attributed to reduced statistical power in female-only analyses 120 
(Fig. 1D,E; Supplementary Table 2). To confirm the association with FSTL5, 121 
rs76811724, which was in high linkage-disequilibrium with rs76973778 (R
2
=0.94; 122 
D’=1), was genotyped in an independent ethnicity-matched cohort (See Methods, Table 123 
S1). The rs76811724 variant showed a highly significant and directionally concordant 124 
association with iTEV in the discovery cohort (Rsq= 0.89, p= 2.06 x10
-7
; OR= 0.39 125 
[0.26-0.58]) and the replication cohort (p= 2.70e
-3
, OR=0.62 [0.44-0.87]). After 126 
combining both the discovery and replication cohorts, the association of rs76811724 127 
exceeded genome-wide significance (p= 2.99 x10
-9
; OR= 0.49 [0.38-0.64]) (Fig. 1F, 128 
Supplementary Table 3), providing further evidence for an association of FSTL5 with 129 
iTEV. 130 
   131 
Embryonic expression of Fstl5 132 
 1 
Little is known regarding the expression of Fstl5 in the hindlimb, and the top-133 
associated rs76973778 was not positioned within an annotated regulatory element 134 
(Supplementary Figure 3A) and was not previously annotated as an expression 135 
quantitative trait locus in human tissues. Therefore to assess whether Fstl5 may regulate 136 
hindlimb development in vivo, we first examined Fstl5 expression in multiple diverse 137 
species. In the developing embryonic bat limb, an emerging species to study conserved 138 
regulatory mechanisms of limb development (19), expression profiling showed Fstl5 was 139 
expressed throughout multiple developmental timepoints, albeit at lower levels compared 140 
to Fstl1 (Fig. 2A). In developing chick embryos, Fstl5 expression was restricted to the 141 
brain early, then was later present in the developing limbs (Fig. 2B).  142 
In mice, RNA-seq analysis of embryonic limb buds detected increasing Fstl5 143 
expression from E12.5 to E13.5 stages of development (Fig. 2C). We then evaluated 144 
expression of multiple Fstl genes in mouse E15.5 forelimb and hindlimb by RT-qPCR. 145 
Fstl1 had the highest expression; however, only Fstl5 was differentially expressed 146 
between forelimb and hindlimb, with significantly higher expression in embryonic mouse 147 
hindlimb (Fig. 2D, Supplementary Figure 2). In all assays, Fstl5 was expressed at lower 148 
levels than Fstl1, which is strongly expressed throughout the entire limb (20). Therefore, 149 
we hypothesized Fstl5 expression may either be expressed at low levels throughout the 150 
entire developing hindlimb or show a spatially restricted expression pattern, leading to 151 
overall low levels of expression. Fstl5 mRNA expression was detected by in situ 152 
hybridization in multiple tissues of the developing E15.5 mouse, including the limb, 153 
forebrain, and heart (Fig. 2E). Closer examination of the mouse hindlimbs showed Fstl5 154 
was strongly and specifically expressed within the condensing cartilage anlage, the 155 
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primary source for chondrocytes during endochondral ossification (Fig. 2F). Together, 156 
these results suggest a potential role for Fstl5 during later stages of embryonic limb 157 
development, following specification and outgrowth. 158 
  159 
Fstl5 is expressed in the post-natal growth plate 160 
To evaluate post-natal expression of Fstl5 in vivo, we utilized Sprague-Dawley rats 161 
harboring a beta-galactosidase insertion (Fstl5
βgeo
) within intron 3 of Fstl5 that resulted in 162 
a premature truncation and significantly reduced expression (Fig. 3A,B). Heterozygous 163 
Fstl5
+/βgeo
 and knock-out Fstl5
 βgeo/βgeo
 rats were born at expected Mendelian (p= 0.38) 164 
and male:female (Binomial p=0.82) ratios with no obvious skeletal or other 165 
developmental abnormalities (Supplementary Tables 4, 5). Using the endogenous 166 
Fstl5
βgeo
 reporter, we found -galactosidase expression was restricted to the pre-167 
hypertrophic chondrocytes of the femur growth plate and, to a lesser extent, in 168 
hypertrophic chondrocytes in 2-week old rats (Fig. 3C). During endochondral 169 
ossification, the embryonic cartilage condensate gives rise to chondrocytes whose 170 
proliferation and maturation in the growth plate regulate subsequent bone formation (21, 171 
22). Thus, the restricted expression of Fstl5 in the embryonic cartilage condensate and 172 
post-natal pre-hypertrophic chondrocytes as well as the lack of gross skeletal 173 
malformations in Fstl5
βgeo/βgeo
 rats suggest a non-essential role for Fstl5 in chondrocyte 174 
maturation (23).  175 
  176 
Sexually dimorphic skeletal development in Prrx1-cre;Fstl5
LSL
 mice 177 
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We sought to test the impact of conditional Fstl5 over-expression in the 178 
osteochondral cell lineage. Conditional over-expression of Fstl5 was tested in mice for 179 
two reasons. First, loss of Fstl5 expression did not result in any observable skeletal 180 
phenotype in Fstl5
βgeo/βgeo
 rats. Second, the orthologous position of the clubfoot-181 
associated rs76973778 allele was within a short segment deleted from the mouse genome, 182 
preventing generation of allele-specific knock-in mice (Supplementary Figure 3A). 183 
Therefore, we engineered Fstl5
LSL
 mice with the Fstl5 coding sequence under the control 184 
of a CAG promoter flanked by LoxP sites (Fig. 3D). The Fstl5
LSL
 expression cassette 185 
was introduced into the ROSA locus using CRISPR/Cas9, and resultant founders were 186 
out-crossed and subsequently inter-crossed with Prrx1-cre mice to generate heterozygous 187 
Prrx1-cre;Fstl5
+/LSL
 breeders. Heterozygous mice were crossed to produce control 188 
(without Prrx1-cre or Fstl5
+/+
), heterozygous, and homozygous (Prrx1-cre;Fstl5
LSL/LSL
) 189 
mice. To confirm Cre-dependent over-expression of Fstl5, bone marrow from 5-month 190 
old mice were flushed, and plastic-adherent bone stromal cells (BSCs) were expanded in 191 
culture and tested for Cre-dependent Fstl5 expression. Fstl5 was not detected in control 192 
BSCs; however, Cre-dependent Fstl5 was robustly expressed in BSCs from Prrx1-193 
cre;Fstl5
LSL
 mice (Fig. 3E,F, Supplementary Figure 3B). Prrx1-cre;Fstl5
LSL
 mice 194 
showed no overt malformations and were visually indistinguishable from litter-mate 195 
control mice. We evaluated skeletal development using X-ray and Dual Energy X-Ray 196 
Absorptiometry (DEXA) imaging. No differences in tibia and femur length or bone 197 
mineral density (BMD) were evident in 3-month old female Prrx1-Fstl5
LSL
 mice 198 
compared to control (Fig. 3G). In contrast, tibia and femur lengths were slightly, though 199 
significantly, reduced in 3-month old male Prrx1-cre;Fstl5
LSL
 mice compared to control 200 
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(Fig. 3H). Additionally, both tibia and femur BMD were significantly reduced in male 201 
Prrx1-cre;Fstl5
LSL
 mice compared to control (Fig. 3H).  202 
  203 
Fstl5-expressing cell lineages are enriched in neuropathic gene signatures 204 
As no overt limb malformations were evident in Fstl5
βgeo
 knock-out rats or in 205 
Prrx1-cre;Fstl5
LSL
 conditional over-expression mice, we sought putative functional 206 
pathways through which Fstl5 may influence hindlimb morphogenesis and development. 207 
For this, we evaluated Fstl5 expression using available mouse embryonic single-cell 208 
transcriptomes (24) (Fig. 4A). Consistent with our in situ expression results (Fig. 2E), 209 
highest levels of Fstl5 expression were evident in neuronal cell lineages, with lower 210 
expression in skeletal lineages, such as “Limb Mesenchyme”, “Osteoblast”, “Chondrocyte 211 
Progenitor”, and “Chondrocyte/Osteoblast” (Supplementary Figure 4). For each 212 
skeletal lineage, expression of Fstl5 was significantly enriched in a single sub-cluster of 213 
cells (Fig. 4A). As the transcriptional landscape of lineage sub-clusters may help to 214 
broadly inform future cell fates (25), we extracted all genes with significantly enriched 215 
expression within Fstl5-expressing sub-clusters and performed pathway analyses. Fstl5-216 
expressing sub-clusters were significantly enriched for genes involved in neural 217 
development and synaptic transmission (Fig. 4B). Neural system genes were significantly 218 
enriched in the Fstl5-expressing sub-clusters of the Chondrocyte progenitor (p=6.60e
-8
), 219 
Chondrocyte and Osteoblast (p=3.46e
-10
), and Osteoblast (p=1.71e
-11
) cell lineages. 220 
These results implicate a potential role for Fstl5 in the neuropathogenesis of iTEV.  221 
  222 
Lineage-specific gene expression suggests functional differences in Fstl proteins 223 
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Fstl proteins were originally named for having follistatin-like domains, suggesting 224 
potential roles in regulating Tgf-ß and BMP signaling, as has been described for Fstl1 225 
(26-28). However, other Fstl family members are less well characterized. Prior 226 
phylogenetic protein analyses identified sequence similarities between Fstl4 and Fstl5, 227 
which clustered most closely with Fstl1, while Fstl3 and Follistatin (Fst) were both 228 
unique (20, 29, 30). We queried expression of Fst and Fstl genes across the 38 mouse 229 
embryonic cell lineages defined by single-cell sequencing of mouse embryos (24). 230 
Surprisingly, hierarchical clustering distinguished patterns of expression between Fstl 231 
genes that resembled phylogenetic analyses based on protein structure (20, 30) (Fig. 4C). 232 
Both Fstl4 and Fstl5 clustered together with highest expression in neural cell lineages. 233 
Consistent with skeletal abnormalities in Fstl1 knock-out mice (27), Fstl1 expression was 234 
highest in mesenchymal and skeletal cell lineages. Fstl3 showed highest expression in the 235 
cardiac cell lineage, among others, and mice lacking Fstl3 were previously shown to 236 
develop cardiac abnormalities resulting in hypertension (31). These results suggest 237 
lineage-specific embryonic expression of Fstl genes in mice correlates with proposed 238 
functional differences among the Fstl family of proteins. 239 
 240 
DISCUSSION 241 
 We identified a locus within a previously uncharacterized gene, FSTL5, 242 
associated with isolated clubfoot. Analysis of Fstl5 in multiple vertebrate embryos 243 
identified conserved expression in the embryonic hindlimb mesenchyme and neural 244 
tissues. Conditional over-expression of Fstl5 in the embryonic limb mesenchyme (using 245 
Prrx1-cre) resulted in reduced BMD in male, but not female, mice, though no gross 246 
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malformations were evident. Finally, we show that evolutionary divergence in the 247 
essential roles of Fstl proteins resembles differences in their lineage-specific expression 248 
in developing mouse embryos (24).  249 
Follistatin-like 5, the protein encoded by FSTL5, is a member of the secreted 250 
protein acidic rich in cysteines (SPARC) family of proteins (30). Follistatin is a secreted 251 
TGF-ß and BMP antagonist, and because Fstl1 harbors a domain with modest sequence 252 
homology to Follistatin, Fstl proteins were hypothesized to also regulate TGF-ß and BMP 253 
signaling (20, 32, 33). Consistent with this, Fstl1 knock-out mice developed lung and 254 
skeletal defects and died shortly after birth from respiratory insufficiency (26, 27). 255 
Skeletal abnormalities included defects in axial skeleton patterning, long bone dysplasia, 256 
and a hindfoot rotational deformity caused by malposition of the distal fibula (27). 257 
Moreover, Fstl1 was shown to promote chondrogenic lineage differentiation of 258 
mesenchymal stromal cells ex vivo (34). However, functional similarities between Fstl1 259 
and other Fstl proteins, such as Fstl5, was unclear. 260 
While the function of FSTL5 was largely unstudied, its mouse homolog (Fstl5) 261 
shared highest sequence similarity to Fstl4, another uncharacterized protein, and Fstl1 262 
(20). Fstl4 expression was localized to neural tissues, and though neurologic differences 263 
were observed in Fstl4 knock-out mice, a lack of gross developmental deformities 264 
suggested Fstl4 likely does not regulate BMP signaling (35, 36). Like Fstl4, Fstl5 was 265 
expressed more highly in neural tissues, and rats lacking Fstl5 showed no gross 266 
developmental malformations. Our results suggest that Fstl5, like Fstl4, does not 267 
modulate Tgf-ß and BMP signaling and is not essential for embryonic skeletal 268 
development, unlike Fst and Fstl1 (26-28, 37). Moreover, lineage-specific expression of 269 
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Fstl genes in mouse embryos is supported by the functional differences between Fstl 270 
proteins and differences in developmental phenotypes among genetically-engineered 271 
mouse models. Expression levels of both Fstl4 and Fstl5 were highest in neural tissues, 272 
while Fstl3 and Fstl1 were expressed highest in cardiac and osteochondroprogenitor 273 
lineages, respectively.  274 
Taken together, these results implicate a neurogenic mechanism and potential 275 
sexually dimorphic role for FSTL5 in iTEV pathophysiology. A neuropathologic 276 
mechanism for clubfoot development is further supported by the recent characterization 277 
of a mouse model of peroneal muscular atrophy (14). Regarding Fstl5, additional 278 
experiments are required to understand what role it plays in the nervous system and how 279 
alterations in Fstl5 function or expression may contribute to limb deformity, potentially 280 
through the use of the conditional transgenic model reported here. As conditional over-281 
expression in skeletal progenitor cells did not result in significant limb deformity, the 282 
impact on limb development following over-expression in neuro-lineage cells remains to 283 
be tested. Finally, analysis of FSTL5 expression in human nervous system tissues is 284 
warranted; however, the correlation to clubfoot pathogenesis may be limited since infants 285 
with isolated clubfoot mostly undergo non-operative treatments. Our results implicate a 286 
neurogenetic pathology to clubfoot pathogenesis. 287 
 288 
MATERIALS AND METHODS 289 
Cohort descriptions 290 
 For the discovery cohort analyses, non-hispanic white clubfoot subjects were 291 
recruited from St Louis Children's Hospital and St Louis Shriners Hospital. The study 292 
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protocol was approved by the Institutional Review Board, and all subjects and/or parents 293 
gave informed consent. Patients were diagnosed at infancy with talipes equinovarus 294 
(clubfoot) based on the physical examination findings by a single orthopedic surgeon. 295 
Exclusion criteria included additional congenital anomalies, developmental delay, or 296 
known underlying etiologies such as arthrogryposis, myelomeningocele, or myopathy. 297 
Control subjects consisted of an ethnicity-matched subset of the Atherosclerosis Risk in 298 
Communities study (ARIC) (18). The ARIC cohort is a prospective community-based 299 
recruitment study focused primarily on atherosclerosis and cardiovascular outcomes. 300 
Ethnicity was confirmed for both cohorts by principal component analysis compared to 301 
HapMap (Supplementary Figure 1A). 302 
 For replication analyses, non-hispanic white clubfoot subjects were recruited from 303 
Scottish Rite for Children (Dallas, TX), Shriners Hospital for Children (Houston, TX), 304 
the St. Louis Children’s Hospital (St. Louis, MO), and St. Louis Shriners Hospital (St. 305 
Louis, MO). All subjects provided written informed consent approved by their respective 306 
Institutional Review Boards. Inclusion and exclusion criteria were the same as for the 307 
discovery cohort. Ethnicity-matched control subjects used for replication were recruited, 308 
in part, from Scottish Rite for Children (Dallas, TX). Additional control subjects were 309 
included from the Dallas Heart Study (38), a multi-ethnic population-based probability 310 
sampling of Dallas County (Dallas, TX), and from a randomized trial with work-place 311 
recruitment from the Dallas-Fort Worth metroplex (39). Recruitment was unrelated to 312 
clubfoot. The allele frequency of the rs76811724 variant among control subjects of the 313 
replication cohort was similar to the allele frequency among non-hispanic whites from the 314 
Gnomad consortium (frequency=0.08). 315 
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 316 
Genome-wide imputation and association 317 
 Genome-wide genotyping of iTEV subjects was performed using the Affymetrix 318 
6.0 microarray as previously described (17). Control subjects available from the 319 
population-based Atherosclerosis Risk in Communities were genotyped on the 320 
Affymetrix 6.0 microarray, and genotype data were obtained from dbGAP [dbGAP: 321 
phs000280]. Quality-control was performed to exclude individuals with evidence of 322 
chromosomal abnormalities, gender inconsistencies, and excessive genotype missingness. 323 
Case and control datasets were merged and genotypes harmonized using Plink v1.9 (40). 324 
Duplicate and related samples were identified using a subset of linkage disequilibrium 325 
(LD)-pruned variants, and only unrelated individuals were included in the imputation. 326 
LD-pruned variants were used for principal component analysis including HapMap Phase 327 
3 samples for ethnicity verification (Supplementary Figure 1A). Prior to imputation, 328 
individual single nucleotide polymorphisms (SNPs) were excluded based on missingness 329 
rate (>5%), minor allele frequency (<0.01), deviation from Hardy-Weinberg equilibrium 330 
(HWE p<1x10
-4
 in controls), non-variant monomorphic SNPs, and SNPs with a 331 
differential missingness rate between case and control cohorts. After filtering, 549,589 332 
autosomal SNPs were available for imputation.  333 
Imputation was performed with MACH v1.0 (41) and Minimac (42) on the 334 
merged case-control cohort following pre-phasing with the 1000 Genomes Phase 3 335 
reference panel. Imputation accuracy (Rsq) was investigated for different ranges of allele 336 
frequency, and a marked decline in the percent of high-quality imputed variants was 337 
evident for those with minor allele frequency <2% (Supplementary Table 6, 338 
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Supplementary Figure 1B). As a majority of imputed variants were rare or 339 
monomorphic and thus poorly imputed, only variants with frequency >2%, Rsq >0.3, and 340 
without significant HWE deviation were included for association analysis. Following 341 
post-imputation filtering, imputed dosages of 7,794,536 variants were included for 342 
logistic regression analysis with Mach2dat, which included gender and ten principle 343 
components as covariates. Association results were plotted using R and LocusZoom (43). 344 
Replication genotyping was performed using allele-discrimination assays 345 
(ThermoFisher). The top-associated variant (rs76973778) was genotyped using a 346 
commercially-available assay; however, the commercial assay was unable to accurately 347 
discriminate between genotypes. Therefore, a custom allele-discrimination assay was 348 
designed to genotype the highly correlated rs76811724 (Supplementary Table 7). The 349 
replication cohort consisted of ethnicity-matched subjects with isolated clubfoot recruited 350 
at St. Louis Children’s Hospital, Shriners Hospital-St. Louis, Scottish Rite for Children, 351 
and Shriners Hospital for Children-Houston. All subjects provided written informed 352 
consent approved by the respective Institutional Review Boards. Genotypes were merged 353 
with the discovery cohort, and association analysis performed using logistic regression 354 




 rats  357 
Generation of Fstl5
βgeo
 rats were previously described (44, 45). Briefly, Sleeping 358 
Beauty β-Geo trap transposons (46) were used to select mutant rat spermatogonial 359 
libraries in vitro (44).  Spermatogonia comprising a selected library were then 360 
transplanted into rat testes for production of mutant spermatozoa (47). Recipient males 361 
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were bred with wildtype females to produce a random panel of donor spermatozoa-362 
derived mutant rat strains enriched with gene traps in protein coding genes (44). Genomic 363 
sites of transposon integration were defined in the newly generated mutant rats by 364 
splinklerette PCR (44) with sequence analysis alignment on genome build RGSC v3.4 365 
(Rn4).  366 
For this study, testis cells from a rat harboring a Sleeping Beauty β-Geo trap 367 
transposon in intron 3 of Fstl5 (44) were thawed from cryopreservation and used to 368 
derive a donor spermatogonial stem cell line that was transplanted into recipient males, as 369 
described (48). Recipient males were bred with wildtype females to regenerate the Fstl5 370 
mutant rat strain. Two founders were established from cryopreservation, both harboring 371 
the Fstl5 intron 3 β-Geo trap transposon. Fstl5 gene-specific PCR primers near Sleeping 372 
Beauty integration sites were used in combination with transposon-specific primers to 373 
genotype progeny (Supplementary Table 8). Fstl5 mutant rats were housed in 374 
individually ventilated, Lab Products 2100 cages in a dedicated room with atmosphere 375 
controls set to 72
o
F, 45-50% humidity during a 12 hour light/dark cycle (i.e. Light cycle 376 
= 6:00am-6:00pm, Central Standard Time adjusted for daylight savings time). Rats were 377 
fed Harlan Teklad Irradiated 7912, LM-485 Mouse/Rat Diet, 5% fat Diet with a 378 
continuous supply of reverse osmosis water. All rat protocols were approved by the 379 
University of Texas Southwestern Medical Center.  380 
 381 
Expression analysis 382 
 For analysis of Fstl5
βgeo
 rats, brain tissue was harvested from 3-week old rats and 383 
homogenized in 500μl TRIzol reagent (Invitrogen). Samples were vortexed and incubated 384 
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at room temperature for 5 minutes and 100μl chloroform added. Samples were vortexed 385 
and centrifuged at 12,000g for 15 minutes at 4°C. RNA was precipitated using 250μl 386 
isopropyl alcohol and incubated at room temperature for 10 minutes followed by 387 
centrifugation at 12,000g for 10 minutes at 4°C.The RNA pellet was subsequently 388 
washed twice with 500μl 75% ethanol followed by centrifugation at 7,500g for 5 minutes 389 
at 4°C. RNA was rehydrated in 50μl nuclease free water and concentrations estimated 390 
using a Nanodrop spectrophotometer. Fstl5 expression was assayed using Sybr-green 391 
qPCR together with Gapdh for normalization. Relative expression levels were compared 392 
using one-sided t-tests compared to Fstl5
+/+
 control. Rat qPCR primer sequences are 393 
listed in Supplementary Table 8. Experimental protocols were approved by the 394 
University of Texas Southwestern Medical Center.  395 
For mouse Fstl limb bud expression, forelimb and hindlimb buds were dissected 396 
from E15.5 embryos, RNA extracted using PureLink RNA Mini kit (Ambion), and 397 
samples pooled (1 litter per pool). cDNA was generated using iScript (BioRad) and qPCR 398 
performed using SybrSelect Mastermix (ThermoFisher). Assays were run in triplicate and 399 
expression normalized to ActinB. Relative expression levels were compared using two-400 
sided t-tests. Mouse qPCR primer sequences are listed in Supplementary Table 8. 401 
Experimental procedures were approved by the Otago University Animal Ethics 402 
committee.  403 
 404 
Immunohistochemistry 405 
 Femurs were dissected from 2-week old Fstl5
βgeo
 rats and fixed in 10% formalin 406 
followed by decalcification in 14% EDTA in PBS and embedded in paraffin.  Four-407 
 1 
micron sections were cut and placed on 3-aminopropyltriethoxysaline (APES)-treated 408 
slides. Slides were dried at 37°C, deparaffinized, and digested in 0.25% Trypsin in 1mM 409 
EDTA for 3 minutes at 37°C incubator. Endogenous peroxidase activity was deactivated 410 
using 3% hydrogen peroxide in Methanol for 10 minutes at room temperature and rinsed 411 
in PBS with 0.1 % Tween 20 (PBST). Sections were blocked in 10% Normal Goat Serum 412 
(Dako) for 30 minutes at room temperature and incubated overnight at 4°C with Anti-413 
Beta Galactosidase Mouse antibody (Promega, 1:500). Following, slides were washed in 414 
PBST 3 times and incubated with HRP-conjugated Goat Anti Mouse IgG Antibody, 415 
(Millipore) for 1.5 hours and washed in PBST 3x. The DAB substrate –chromogen 416 
(DAKO) was applied for 10 minutes, counterstained in Mayer’s hematoxylin for 2 417 
minutes, and washed in distilled water.  Sections were dehydrated in alcohol, cleared in 418 
xylene, and mounted with Cytoseal XYL (Thermo Scientific) prior to imaging with a 419 
DP73 Olympus microscope using Cell Sens software. 420 
 421 
In situ hybridization 422 
A 505 bp region of the mouse Fstl5 mRNA was amplified from embryonic E15.5 423 
hindlimb cDNA using oligonucleotide primers (Fstl5F:5’-424 
GGAAGGCTAAGCTCTGCATATT-3’, and Fstl5R:5’-425 
GCACTACAGAGAGTGGTTTCAG-3’). The PCR product was cloned into 426 
pGEMTEasy (Promega) and sequenced to confirm orientation. Dioxigenin (DIG)-427 
labelled probe synthesis (sense and anti-sense) was carried out as published previously 428 
(49).  429 
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Embryos from time-mated mice were removed and frozen in OCT prior to 430 
sectioning (10 m) for in situ hybridization. Thawed sections were air-dried and fixed 431 
with 4% paraformaldehyde (PFA)/phosphate buffered saline (PBS) for 10 min, washed 432 
with PBT (PBS with 10% Tween-20) three times before proteinase K digestion (1 g/ml 433 
for 10 min). Following, sections were re-fixed with PFA/PBS and acetylated (625 l 434 
acetic anhydride and 295 ml 0.1 M triethanolamine) for 10 min at room temperature. 435 
Sections were washed three times with PBT prior to hybridization with the appropriate 436 
sense or anti-sense probe in hybridization buffer (50% formamide, 5x saline sodium 437 
citrate buffer (SSC), 5x Denhardts, 250 g/ml yeast RNA, 500 g/ml herring sperm 438 
DNA).  Slides were incubated overnight at 65°C in a humidified chamber. Post-439 
hybridization washes were done at 65°C with a series of wash buffers (1xSSC/50% 440 
formamide; 2xSSC and 0.2x SSC (twice)) for 20 min each. Sections were washed twice 441 
at room temperature with maleic acid buffer with Tween 20 (MABT) before blocking 442 
with 20% heat inactivated sheep serum (HISS), 2 % Roche blocking powder in MABT. 443 
To detect the DIG-probe, slides were incubated overnight at 4°C with anti-DIG-alkaline 444 
phosphatase (Roche) diluted 1:2,500 in 5% HISS/MABT. Unbound antibody was 445 
removed by washing with MABT, followed by NTM buffer (100mM NaCl, 100mM 446 
Tris.Cl (pH 9.5), 50mM MgCl2) with nitro blue tretrazolium (NBT) and 5-bromo-4-447 
chloro-3-indolyl-phostphate (BCIP) (Roche) to detect alkaline phosphatase. Following 448 
the color reaction, slides were washed and fixed with 4% PFA/PBS before mounting for 449 
imaging. Sections were imaged on an Olympus AX70 light microscope. All mouse 450 
experimental protocols were approved by the Otago University Animal Ethics committee.  451 
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Chicken Fstl5 was cloned from a cDNA library from day 4 chicken embryos 452 
using PCR primers and subcloned into a pBS vector. In-situ hybridization analysis was 453 
carried out using previously published methods (50, 51). Experimental procedures were 454 
performed in accordance with UK Home Office Animal licensing and in accordance with 455 
University of Aberdeen ethical review committees. 456 
 457 
Generation of the Fstl5
LSL
 mouse line 458 
 A vector containing the CAG promoter flanked by LoxP sites upstream of the 459 
Fstl5 coding sequence was designed, produced, and purified using VectorBuilder 460 
(https://en.vectorbuilder.com) and Cyagen US (Santa Clara, CA). Mice were engineered 461 
using CRISPR/Cas9 via pronuclear injection of 1-cell stage C57BL/6N embryos. 462 
Injections included 25ng/uL Cas9 protein (Integrated DNA Technologies), 25ng/uL 463 
crRNA (5’-CGCCCATCTTCTAGAAAGAC-3’) complexed with tracRNA scaffold, and 464 
10ng/uL circular plasmid, diluted in TE buffer. Following injection, embryos were 465 
implanted into pseudo-pregnant females. Multiple founder lines were established and 466 
maintained by out-crossing to C57BL/6J mice.  467 
 Fstl5
LSL
 mice were crossed to Prrx1-cre mice, and resulting Prrx1-cre;Fstl5
+/LSL
 468 







 homozygous mice. Cre and Fstl5
LSL
 genotyping 470 
primer sequences are provided in Supplementary Table 8. Cre-induced over-expression 471 
was validated by qPCR and Western blotting using cultured bone stromal cells from 472 
adults Prrx1-cre;Fstl5
LSL
 mice compared to control.   473 
 1 
Mouse protocols were approved by the UT Southwestern Medical Center 474 
Institutional Animal Care and Use Committee. 475 
 476 
Cell culture, expression analysis, and western blotting  477 
For ex vivo bone stromal cell culture, bone marrow was flushed from adult mice 478 
and cultured in alpha-MEM (Thermofisher Scientific) with 10% FBS (Sigma) and 1% 479 
antibiotics (penicillin/streptomycin) (Thermofisher Scientific) for 5 days at 37°C and 5% 480 
CO2. Following, media was refreshed and non-plastic adherent cells washed away. The 481 
cells were then plated in 12-well plates and 100mm plates for RNA and protein 482 
extraction, respectively and grown to confluence. 483 
For RNA extraction, the cells were harvested in RLT Plus buffer with beta-484 
marcaptoethanol (Sigma). The cells were passed through Qiashredder columns (Qiagen) 485 
prior to RNA extraction. RNeasy Plus Mini Kit (Qiagen) was used to extract RNA 486 
following manufacturer’s recommendations. The samples were quantified using a 487 
Nanodrop1000 spectrophotometer (Thermofisher Scientific). cDNA synthesis was 488 
performed using the High Capacity RNA to cDNA Kit (Thermofisher Scientific). The 489 
qPCR assays were performed using SYBR Green PCR Master Mix (Thermofisher 490 
Scientific). Protein was extracted using RIPA buffer with protease inhibitor cocktail 491 
(Roche)  and concentration was determined using the Pierce BCA Protein Assay 492 
(Thermofisher Scientific). Approximately 10μg of protein was loaded on SDS-PAGE. 493 
The antibody detection was performed using rabbit anti-Fstl5 (1:2,000) and rabbit anti-494 
Actb (1:5,000) (Cell Signaling Technologies) in 5% BSA in TBST buffer overnight at 495 
4°C. After washing, goat anti-rabbit (1:10,000) IRDye secondary antibody (Licor 496 
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Biosciences) was incubated in 5% nonfat dry milk in TBST buffer for 1 hour at room 497 
temperature in the dark. Following washing, images were acquired using the Odyssey 498 
CLx system (Licor Biosciences).   499 
 500 
Skeletal assessments 501 
 For live-animal rodent imaging, mice were anesthetized using 2% inhaled 502 
isoflurane. Images were acquired using a Faxitron UltrafocusDXA. Bone densities and 503 
bone lengths were measured using Faxitron software and compared to litter-mate controls 504 
using two-sided t-tests.  505 
 506 
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 690 
FIG. LEGENDS 691 
Fig. 1. Fstl5 is associated with isolated clubfoot. (A) Clinical image of an infant with 692 
bilateral clubfoot. (B) Manhattan plot of genome-wide association results. Dashed line 693 
represents genome-wide significance (5x10
-8
). Only the Fstl5 locus exceeded genome-694 
wide significance. (C-E) LocusZoom plot showing association of rs76973778 (purple 695 
circle) within the FSTL5 locus in (C) the entire cohort, (D) males only, and (E) females 696 
only. (F) Variant rs76811724 (purple circle) was genotyped for replication. This variant 697 
exceeded genome-wide significance following meta-analysis combining the original and 698 
replication cohorts (purple diamond). 699 
 700 
Fig. 2. Evolutionarily conserved expression of Fstl5 in the developing limb. (A) 701 
Expression of bat Fstl1, Fstl4 and Fstl5 in developing forelimb and hindlimb at 702 
embryonic stages CS15, CS16, and CS17 quantified using RNA-seq. Timepoints 703 
correspond to similarly staged mouse limb development shown in panel C. (B) Whole-704 
mount in situ hybridization showing embryonic expression of chick Fstl5. Expression 705 
becomes evident during later stages of limb development. (C) Expression of mouse Fstl1, 706 
Fstl4, and Fstl5 in developing forelimb and hindlimb at embryonic stages E12, E13, and 707 
E13.5 quantified using RNAseq. Timepoints correspond to similarly staged bat limb 708 
development shown in panel A. (D) Differential expression of mouse Fstl5 in E15.5 709 
 1 
forelimb and hindlimb measured by RT-qPCR (n=3 independent biological replicates). 710 
Data represented as mean +/- standard error. Statistically significant differences were 711 
determined using two-sided T-test. ***, p<0.001. (E) Mouse E15.5 in situ hybridization 712 
showing Fstl5 expression throughout the (i) entire embryo, (ii) forebrain, and (iii) heart. 713 
(F) In situ hybridization of mouse embryonic E15.5 distal hindlimb showing localized 714 
expression of Fstl5 to the condensing cartilage mesenchyme. 715 
 716 
Fig. 3. In vivo characterization of Fstl5. (A) Schematic diagram of Sleeping Beauty 717 
insertion of β-galactosidase within intron 3 of rat Fstl5, predicted to result in premature 718 
truncation. (B) Expression of Fstl5 in brain tissue from control (Fstl5
+/+
), heterozygous 719 
(Fstl5
+/βgeo
), and homozygous (Fstl5
βgeo/βgeo
) rats (n=3-5 animals per genotype). 720 
Statistically significant differences were determined by a one-sided T-test. Data 721 
represented as mean +/- standard error. (C) Immunohistochemistry showing ( -722 
galactosidase) expression in the pre-hypertrophic chondrocytes of the femur growth plate 723 
of 2-week old Fstl5
βgeo
 rats. Expression diminishes in the hypertrophic chondrocytes of 724 
the growth plate. Similar results were seen in tibia and metatarsal growth plates (data not 725 
shown). (D) Schematic diagram of the Fstl5
LSL
 conditional over-expression cassette 726 
within the mouse ROSA locus. (E and F) Confirmation of cre-induced over-expression of 727 
Fstl5 in bone stromal cells cultured from Prrx1-cre;Fstl5
LSL
 mice compared to control by 728 
(E) qPCR and (F) Western blot. For western blotting, beta-actin is shown as loading 729 
control. * indicates background band from Fstl5 antibody. (G,H) Skeletal phenotypes of 730 
3-month old (G) female and (H) male Prrx1-cre;Fstl5
LSL
 mice (grey) compared to age- 731 
and gender-matched littermate controls (black). Data represented as mean +/- standard 732 
 1 
error. Statistically significant differences were determined using 2-sided T-tests. *, 733 
p<0.05; **, p<0.01. 734 
 735 
Fig. 4. Analyses of mouse embryonic single-cell gene expression. (A) Schematic of Fstl5 736 
expression analyses using publicly-available results from mouse embryonic scRNAseq 737 
(ref. 28). (B) Enrichment of Reactome pathways for Fstl5-expressing sub-clusters. (C) 738 
Bi-clustering of Fstl genes and their expression across the various cell lineages. 739 
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